Thompson, R. J., Arnell, H., Artan, R., Baumann, U., Calvo, P. L., Czubkowski, P., Dalgic, B., D'Antiga, L., Durmaz, Ö., Fischler, B., Gonzalès, E., Grammatikopoulos, T., Gupte, G., Hardikar, W., Houwen, R. H. J., Kamath, B. M., Karpen, S. J., Kjems, L., Lacaille, F., Lachaux, A., Lainka, E., Mack, C. L., Mattsson, J. P., McKiernan, P., Özen, H., Rajwal, S. R., Roquelaure, B., Shagrani, M., Shteyer, E., Soufi, N., Sturm, E., Tessier, M. E., Verkade, H. J., & Horn, P. (2022). odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet gastroenterology and hepatology, 7, 830–842. http://access.bl.uk/ark:/81055/vdc_100160179006.0x000005